000			02110 a2200577 4500
005			20250513205958.0
264		0	_c20000607
008			200006s 0 0 eng d
022			_a0168-0102
024	7		_a10.1016/s0168-0102(00)00097-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aAoi, M
245	0	0	_aThe effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. _h[electronic resource]
260			_bNeuroscience research _cApr 2000
300			_a319-25 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApomorphine _xpharmacology
650	0	4	_aAxons _xmetabolism
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDopamine Agonists _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFunctional Laterality
650	0	4	_aGlial Cell Line-Derived Neurotrophic Factor
650	0	4	_aImmunohistochemistry
650	0	4	_aMovement _xdrug effects
650	0	4	_aNeostriatum _xdrug effects
650	0	4	_aNerve Degeneration _xdrug therapy
650	0	4	_aNerve Growth Factors
650	0	4	_aNerve Tissue Proteins _xpharmacology
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aOxidopamine _xpharmacology
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRotation
650	0	4	_aSubstantia Nigra _xdrug effects
650	0	4	_aSympatholytics _xpharmacology
650	0	4	_aTime Factors
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
650	0	4	_aWeight Loss _xdrug effects
700	1		_aDate, I
700	1		_aTomita, S
700	1		_aOhmoto, T
773	0		_tNeuroscience research _gvol. 36 _gno. 4 _gp. 319-25
856	4	0	_uhttps://doi.org/10.1016/s0168-0102(00)00097-3 _zAvailable from publisher's website
999			_c10724244 _d10724244